Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
Canaccord Genuity Morning Coffee on Infosys (INFY): The Times, They are a-Changin'
-
Shares of 3D Systems (DDD) Continue on a Tear, Adding to 115% Gain Year-To-Date
-
Canaccord Genuity Maintains a 'Hold' on AngioDynamics (ANGO); Bumping Estimates After Q4 Results
-
Natural Grocers (NGVC) Sees IPO Price of $13 - $15/Share
-
Canaccord Genuity Reiterates a 'Buy' on Quidel Corp. (QDEL); Q2 Preview: Exciting Launch in Series of New Products
-
Canaccord Genuity Q2 Preview on Quest Diagnostics (NYSE: DGX): Sidelined Until More Confident in New CEO's Ability
-
Canaccord Genuity Maintains a 'Buy' on OraSure Technologies (OSUR); Q2 Preview: Build on its Momentum
-
Canaccord Genuity Maintains a 'Buy' on Meridian Biosciences (VIVO); Q3 Preview: Performing Well Despite Hurdles
-
Canaccord Genuity Maintains a 'Buy' on Laboratory Corporation (LH); Q2 Preview: Successful Commercial Lab Business
-
Canaccord Genuity Maintains a 'Hold' on Genomic Health (GHDX); Q2 Preview: Is Strong Growth Attainable?
-
Canaccord Genuity Maintains a 'Buy' on GenMark Diagnostics (GNMK); Q2 Preview: Expecting Really Good Numbers
-
Canaccord Genuity maintains a 'Buy' on Exact Sciences (EXAS); Q2 Preview: Unique Opportunity Presented
-
Canaccord Genuity Maintains a 'Buy' on Cepheid (CPHD); Q2 Preview: Consumable Growth is Key
-
Canaccord Genuity Maintains a 'Hold' on Becton Dickinson (BDX); Q3 Preview: Looking For Signs of Stabilization
-
Canaccord Genuity Maintains a 'Hold' on AspenBio Pharma (APPY); Q2 Preview: Trials For AppyScore Start Soon
-
Canaccord Genuity Maintains a 'Buy' on Alere (ALR); Q2 Preview: Looking for Clarity
-
Canaccord Genuity Q1 Preview on Abaxis Inc. (ABAX): Too Far, Too Fast
-
Canaccord Genuity on Amazon.com (AMZN): Achievement Unlocked
-
Canaccord Genuity Maintains a 'Hold' on Badger Meter (BMI); Remain Comfortable with Q2 Estimates
-
Canaccord Genuity Maintains a 'Buy' on Xylem (XYL); Cutting Price Target Ahead of Quarterly Results
-
Canaccord Genuity Maintains a 'Hold' on Pentair (PNR); June Quarter Preview
-
Canaccord Genuity Suggests Buying Hologic (HOLX) on Weakness After Mixed Q3 Pre-Announcement
-
Canaccord Genuity Assumes Coverage on Optimer Pharmaceuticals (OPTR) at Buy; Near Term Growth Driven by Unmet Need
-
Canaccord Genuity Maintains a 'Buy' on NVIDIA (NVDA); Upstream Checks Still Positive Despite Weak PCs
-
Canaccord Genuity Reiterates a 'Buy' on Rosetta Resources (ROSE); NGL Weakness Priced In; Greater Oil Emphasis Isn't
-
Canaccord Genuity Downgrades Perrigo Co. (PRGO) to Hold; Limited Upside; Prefers Watson (WPI)
-
Streetinsider.com's Hot Lunchtime Reads 07/11: (BAH) (DE) (JPM) (FB) (QCOR)
-
Canaccord Genuity Morning Coffee on Intel (INTC): An Intelligent Buy?
-
Canaccord Genuity Morning Coffee on J.C. Penney (JCP): Penney Pinched
-
Canaccord Genuity Morning Coffee on Facebook (FB) and LinkedIn (LNKD): Poke! You Have Received an Interview
-
Canaccord Genuity Morning Coffee on Cummins (CMI) and Westport (WPRT): Backfired
-
Canaccord Genuity Morning Coffee on Portfolio Strategy: Set The Bar Low
-
Canaccord Genuity Maintains a 'Buy' on DIRECTV (DTV); Holding Leverage in Viacom (VIAB) Dispute
-
OraSure (OSUR) Commences $75M Common Offering
-
OraSure (OSUR) Prices 6.1M Offering at $12.30/Share
-
Canaccord Genuity Morning Coffee on PepsiCo (PEP): Yogurt Wars
-
Canaccord Genuity Morning Coffee on Boeing (BA): That's My...
-
Intel's (INTC) Little Step-Brother...Mr. Can't Get Right (AMD)
-
Canaccord Genuity Reiterates a 'Buy' on Vascular Solutions (VASC); Expect Strong Q2 - Add to Positions
-
Canaccord Genuity Reiterates a 'Hold' on MAKO Surgical (MAKO); Smelling Blood in the Water
-
Canaccord Genuity Maintains a 'Buy' on Liberty Media (LMCA); More Compelling Case as SIRI Shares Rise
-
Canaccord Genuity Maintains a 'Buy' on LinkedIn (LNKD); Expect Limited Threat From Facebook (FB)
-
Canaccord Genuity Maintains a 'Buy' on AMD (AMD); Cutting PT and Estimates; No One Immune From PC Weakness
-
Canaccord Genuity Maintains a 'Buy' on Forest Oil (FST); The Other Shoe Drops on Q2 Pre-Announcement
-
OraSure (OSUR) Announces Offering of $75M in Common Shares
-
Canaccord Genuity on Telecommunications: Data Points Continue to Favor Data Centers and Tower Stocks
-
Canaccord Genuity Reiterates a 'Buy' on Anthera Pharma (ANTH); B-Mod Still Has A Shot
-
Canaccord Genuity Maintains a 'Buy' on Gevo, Inc. (GEVO); Volatility Continues From Litigation
-
Canaccord Genuity Starts DSW Inc. (DSW) at Hold; Looking For The Second Shoe To Drop
-
Canaccord Genuity Morning Coffee on Apple (AAPL): Google Probably Would Have Invented A Shrink Ray, But This Is Okay Too

